Received Sep 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
was diagnosed with shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced shingles (Verbatim: was diagnosed with shingles). The outcome of the shingles was not resolved. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date: 23-SEP-2025 This case was reported by a patient via interactive digital media. The patient had both shots and was diagnosed with shingles. Now the patient was in fourth week and shingles was so painful.; Sender's Comments: US-GSK-US2025AMR124431:Same patient 2nd dose